The fitness costs and benefits of trisomy of each Candida albicans chromosome.
Candida albicans
aneuploidy
antifungal drugs
fitness benefits
fitness costs
monosomy
trisomy; tetrasomy
Journal
Genetics
ISSN: 1943-2631
Titre abrégé: Genetics
Pays: United States
ID NLM: 0374636
Informations de publication
Date de publication:
24 06 2021
24 06 2021
Historique:
accepted:
01
04
2021
received:
21
01
2021
pubmed:
11
4
2021
medline:
22
2
2022
entrez:
10
4
2021
Statut:
ppublish
Résumé
Candida albicans is a prevalent human fungal pathogen. Rapid genomic change, due to aneuploidy, is a common mechanism that facilitates survival from multiple types of stresses including the few classes of available antifungal drugs. The stress survival of aneuploids occurs despite the fitness costs attributed to most aneuploids growing under idealized lab conditions. Systematic study of the aneuploid state in C. albicans has been hindered by the lack of a comprehensive collection of aneuploid strains. Here, we describe a collection of diploid C. albicans aneuploid strains, each carrying one extra copy of each chromosome, all from the same genetic background. We tested the fitness of this collection under several physiological conditions including shifts in pH, low glucose, oxidative stress, temperature, high osmolarity, membrane stress, and cell wall stress. We found that most aneuploids, under most conditions, were less fit than their euploid parent, yet there were specific conditions under which specific aneuploid isolates provided a fitness benefit relative to the euploid parent strain. Importantly, this fitness benefit was attributable to the change in the copy number of specific chromosomes. Thus, C. albicans can tolerate aneuploidy of each chromosome and some aneuploids confer improved growth under conditions that the yeast encounters in its host niches.
Identifiants
pubmed: 33837402
pii: 6218773
doi: 10.1093/genetics/iyab056
pmc: PMC8225349
pii:
doi:
Substances chimiques
Antifungal Agents
0
Banques de données
figshare
['10.25386/genetics.14349062']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI143689
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of Genetics Society of America. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
PLoS Genet. 2019 May 15;15(5):e1008137
pubmed: 31091232
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S79-S94
pubmed: 30895218
Science. 2006 Jul 21;313(5785):367-70
pubmed: 16857942
Mol Microbiol. 2006 Sep;61(5):1147-66
pubmed: 16925551
Appl Environ Microbiol. 1999 Aug;65(8):3325-7
pubmed: 10427014
Nat Commun. 2018 May 22;9(1):1936
pubmed: 29789543
Genome Biol. 2007;8(4):R52
pubmed: 17419877
Nature. 2018 Apr;556(7701):339-344
pubmed: 29643504
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Elife. 2020 Jan 07;9:
pubmed: 31909711
Nature. 2015 Mar 19;519(7543):349-52
pubmed: 25731168
Science. 2007 Aug 17;317(5840):916-24
pubmed: 17702937
PLoS Genet. 2008 Jan;4(1):e1
pubmed: 18179283
Elife. 2015 Feb 03;4:e00662
pubmed: 25646566
Antimicrob Agents Chemother. 2013 Oct;57(10):5026-36
pubmed: 23896475
Genome Biol. 2013;14(9):R97
pubmed: 24025428
Cancer Res. 2017 Nov 1;77(21):e31-e34
pubmed: 29092934
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Mol Microbiol. 2008 May;68(3):624-41
pubmed: 18363649
Eukaryot Cell. 2009 Oct;8(10):1554-66
pubmed: 19700634
Nature. 2010 Nov 11;468(7321):321-5
pubmed: 20962780
Nat Commun. 2018 Jun 25;9(1):2470
pubmed: 29941885
Cell. 2012 Jul 6;150(1):151-64
pubmed: 22727045
Nature. 2019 Jun;570(7759):117-121
pubmed: 31068692
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5150-5
pubmed: 9560244
PLoS Genet. 2010 Apr 01;6(4):e1000893
pubmed: 20369021
Mol Syst Biol. 2015 Oct 12;11(10):832
pubmed: 26459777
Mol Biol Evol. 2019 Aug 1;36(8):1768-1782
pubmed: 31028698
EMBO J. 2003 May 15;22(10):2505-15
pubmed: 12743044
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28223384
Antimicrob Agents Chemother. 2005 Jun;49(6):2226-36
pubmed: 15917516
PLoS Pathog. 2010 Apr 01;6(4):e1000848
pubmed: 20368972
Genes (Basel). 2019 Oct 10;10(10):
pubmed: 31658789
Cancer Sci. 2008 Aug;99(8):1539-45
pubmed: 18754864